The CEO of UBI get paid based on the last reporting around $482,917 per year to manage loss making company with annual revenue of $6.6m while another ASX listed medical device company with revenue of $300 m pays their CEO $500,000.
Even after paying so much high salary to UBI CEO, what did the shareholder got in return ? A shit show after the FDA approval in my opinion. Significantly discounted shares and possibly if next credit raise continue then discounted shares with free options so buying cost will be even low and dilution will be high in my opinion.
Who still has confidence in the Board and CEO ?
This is eye opening for shareholder who keep approving remuneration report without reading in my opinion.
PGC annual report abstract. John is the CEO and his pay is $500,000 plus super (based on latest notice).
I hold PGC & UBI both, so no cross promotion here.
The CEO of UBI get paid based on the last reporting around...
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.020(11.8%) |
Mkt cap ! $34.71M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.0¢ | $1.574M | 9.553M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 250000 | 1 |
View Market Depth
| Last trade - 15.50pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
15.5¢ |
Change
-0.020 ( 6.06 %) |
||||
| Open | High | Low | Volume | ||
| 15.0¢ | 15.5¢ | 15.0¢ | 24000 | ||
| Last updated 14.11pm 26/04/2024 ? | |||||
| UBI (ASX) Chart |